HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
Clinical Trial: UPENN's BCMA CAR T Cell Clinical Trial for Myeloma Relapsed/Refractory Patients
Posted: Apr 04, 2017
Clinical Trial: UPENN's BCMA CAR T Cell Clinical Trial for Myeloma Relapsed/Refractory Patients image

CAR T Cell therapy is an important new advance in myeloma treatment. In this immunotherapy protocol, a patient's T cells are removed via a blood draw. Then their T Cells are engineered to target a specific protein found on the surface of myeloma cells and are given back to the patient. The  University of Pennsylvania and the NIH have led the way on these trials in the United States both for the CD19 protein (typically not found on the surface of myeloma cells) and the BCMA protein (found on the surface of most myeloma cells). Currently, a Phase I study is open with the intent to include 27 relapsed/refractory myeloma patients at the University of Pennsylvania. Nine patients have already been treated and higher dose levels have been implemented. The level of BCMA expression can vary by patient, but there is no inclusion or exclusion criteria for this in joining the trial. Note: This trial currently has a waitlist due to patient demand and the time required to customize each patient's CAR T Cells.  The Myeloma Crowd Research Initiative is funding similar CAR T Cell work targeting BCMA and we are excited to see international progress in these trials. To learn more, watch the video with Adam Cohen, MD of UPENN and click the link below: BCMA CAR T Cell Trial  

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Amgen Oncology
Abbvie
Genentech
GSK
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube